Real-Time European Filings API. Request Access
scPharmaceuticals Inc. Logo

scPharmaceuticals Inc.

Commercializes subcutaneous drug-device therapies for at-home cardiorenal care.

SCPH | US

Overview

Corporate Details

ISIN(s):
US8106481059
LEI:
Country:
United States of America
Address:
25 BURLINGTON MALL ROAD, SUITE 203, 1803 BURLINGTON
Website:
https://www.scpharmaceuticals.com/
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

scPharmaceuticals Inc. is a commercial-stage pharmaceutical company, operating as a subsidiary of MannKind Corporation, focused on developing and commercializing patient-centric treatments for cardiorenal diseases. The company specializes in drug-device combinations that facilitate subcutaneous drug delivery, aiming to improve patient outcomes and shift care from clinical settings to the home. Its flagship product, FUROSCIX®, is a proprietary formulation of furosemide delivered via an auto-injector for treating congestion in patients with heart failure and, as of 2025, chronic kidney disease. The company's strategy centers on creating value-based solutions that reduce the burden of care and enhance quality of life for patients with cardiovascular and renal conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all scPharmaceuticals Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for scPharmaceuticals Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for scPharmaceuticals Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Shedir Pharma Group Logo
Shedir Pharma Group
Develops and sells pharmaceutical, nutraceutical, and dermo-cosmetic products in Italy & Spain.
Italy
SHE
SHIELD THERAPEUTICS PLC Logo
SHIELD THERAPEUTICS PLC
Commercializing a novel oral therapy for adults with iron deficiency.
United Kingdom
STX
SHINPOONG PHARMACEUTICAL CO.,LTD Logo
SHINPOONG PHARMACEUTICAL CO.,LTD
R&D-driven pharma firm making APIs, finished drugs, and medical products for global markets.
South Korea
019170
Shionogi & Co.,Ltd. Logo
Shionogi & Co.,Ltd.
A research-driven pharmaceutical firm creating drugs, diagnostics, and devices for global health.
Japan
4507
Shuttle Pharmaceuticals Holdings, Inc. Logo
Shuttle Pharmaceuticals Holdings, Inc.
Develops drugs to enhance radiation therapy for cancer and offers predictive diagnostics.
United States of America
SHPH
Siegfried Holding AG Logo
Siegfried Holding AG
Global CDMO providing development and manufacturing of APIs and finished drugs for the pharma industry.
Switzerland
SFZN
SIGA TECHNOLOGIES INC Logo
SIGA TECHNOLOGIES INC
Develops antiviral drugs for global health security against biothreats and infectious diseases.
United States of America
SIGA
Silexion Therapeutics Corp Logo
Silexion Therapeutics Corp
Developing a local drug delivery platform to treat KRAS-driven cancers and solid tumors.
United States of America
SLXN
SillaJen, Inc.
Develops oncolytic viruses and immunotherapeutics to destroy difficult-to-treat cancer cells.
South Korea
215600
Silo Pharma, Inc. Logo
Silo Pharma, Inc.
Develops novel psychedelic & traditional therapies for pain and central nervous system disorders.
United States of America
SILO

Talk to a Data Expert

Have a question? We'll get back to you promptly.